Safety and efficacy of tenecteplase versus alteplase in patients with acute ischaemic stroke (TRACE): a multicentre, randomised, open label, blinded-endpoint (PROBE) controlled phase II study
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
|
| Series: | Stroke and Vascular Neurology |
| Online Access: | https://svn.bmj.com/content/early/2021/08/23/svn-2021-000978.full |
| _version_ | 1818732327817183232 |
|---|---|
| author | Huisheng Chen Dong Wang Wanliang Du Huaguang Zheng Ziran Wang Zhigang Liang |
| author_facet | Huisheng Chen Dong Wang Wanliang Du Huaguang Zheng Ziran Wang Zhigang Liang |
| author_sort | Huisheng Chen |
| collection | DOAJ |
| first_indexed | 2024-12-17T23:31:49Z |
| format | Article |
| id | doaj.art-17c41bbf856f44e1a101f2af884def66 |
| institution | Directory Open Access Journal |
| issn | 2059-8696 |
| language | English |
| last_indexed | 2024-12-17T23:31:49Z |
| publisher | BMJ Publishing Group |
| record_format | Article |
| series | Stroke and Vascular Neurology |
| spelling | doaj.art-17c41bbf856f44e1a101f2af884def662022-12-21T21:28:38ZengBMJ Publishing GroupStroke and Vascular Neurology2059-869610.1136/svn-2021-000978Safety and efficacy of tenecteplase versus alteplase in patients with acute ischaemic stroke (TRACE): a multicentre, randomised, open label, blinded-endpoint (PROBE) controlled phase II studyHuisheng Chen0Dong Wang1Wanliang Du2Huaguang Zheng3Ziran Wang4Zhigang Liang5Department of Neurology, General Hospital of Northern Theatre Command, Shenyang, Liaoning, ChinaDepartment of Neurology, Baogang Hospital of Inner Monglia, Inner Monglia, ChinaDepartment of Neurology, Beijing Tiantan Hospital, Beijing, ChinaNeurology, Beijing Tiantan Hospital, Beijing, ChinaDepartment of Neurology, Linyi People`s Hospital, Linyi, ChinaDepartment of Neurology, Affiliated Yantai Yuhuangding Hospital of Qingdao University Medical College, YanTai, Chinahttps://svn.bmj.com/content/early/2021/08/23/svn-2021-000978.full |
| spellingShingle | Huisheng Chen Dong Wang Wanliang Du Huaguang Zheng Ziran Wang Zhigang Liang Safety and efficacy of tenecteplase versus alteplase in patients with acute ischaemic stroke (TRACE): a multicentre, randomised, open label, blinded-endpoint (PROBE) controlled phase II study Stroke and Vascular Neurology |
| title | Safety and efficacy of tenecteplase versus alteplase in patients with acute ischaemic stroke (TRACE): a multicentre, randomised, open label, blinded-endpoint (PROBE) controlled phase II study |
| title_full | Safety and efficacy of tenecteplase versus alteplase in patients with acute ischaemic stroke (TRACE): a multicentre, randomised, open label, blinded-endpoint (PROBE) controlled phase II study |
| title_fullStr | Safety and efficacy of tenecteplase versus alteplase in patients with acute ischaemic stroke (TRACE): a multicentre, randomised, open label, blinded-endpoint (PROBE) controlled phase II study |
| title_full_unstemmed | Safety and efficacy of tenecteplase versus alteplase in patients with acute ischaemic stroke (TRACE): a multicentre, randomised, open label, blinded-endpoint (PROBE) controlled phase II study |
| title_short | Safety and efficacy of tenecteplase versus alteplase in patients with acute ischaemic stroke (TRACE): a multicentre, randomised, open label, blinded-endpoint (PROBE) controlled phase II study |
| title_sort | safety and efficacy of tenecteplase versus alteplase in patients with acute ischaemic stroke trace a multicentre randomised open label blinded endpoint probe controlled phase ii study |
| url | https://svn.bmj.com/content/early/2021/08/23/svn-2021-000978.full |
| work_keys_str_mv | AT huishengchen safetyandefficacyoftenecteplaseversusalteplaseinpatientswithacuteischaemicstroketraceamulticentrerandomisedopenlabelblindedendpointprobecontrolledphaseiistudy AT dongwang safetyandefficacyoftenecteplaseversusalteplaseinpatientswithacuteischaemicstroketraceamulticentrerandomisedopenlabelblindedendpointprobecontrolledphaseiistudy AT wanliangdu safetyandefficacyoftenecteplaseversusalteplaseinpatientswithacuteischaemicstroketraceamulticentrerandomisedopenlabelblindedendpointprobecontrolledphaseiistudy AT huaguangzheng safetyandefficacyoftenecteplaseversusalteplaseinpatientswithacuteischaemicstroketraceamulticentrerandomisedopenlabelblindedendpointprobecontrolledphaseiistudy AT ziranwang safetyandefficacyoftenecteplaseversusalteplaseinpatientswithacuteischaemicstroketraceamulticentrerandomisedopenlabelblindedendpointprobecontrolledphaseiistudy AT zhigangliang safetyandefficacyoftenecteplaseversusalteplaseinpatientswithacuteischaemicstroketraceamulticentrerandomisedopenlabelblindedendpointprobecontrolledphaseiistudy |